Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (3) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Orphan designations Remove Orphan designations filter Periodic safety update report single assessments Remove Periodic safety update report single assessments filter Shortages Remove Shortages filter Withdrawn applications (9) Apply Withdrawn applications filter Paediatric investigation plans (168) Apply Paediatric investigation plans filter Referrals (16) Apply Referrals filter Direct healthcare professional communication (29) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (10) Apply Yes filter

Authorisation status

Authorised (350) Apply Authorised filter Refused (1) Apply Refused filter Withdrawn (48) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (18) Apply Positive filter

Application type

Initial authorisation (1) Apply Initial authorisation filter Post-authorisation (17) Apply Post-authorisation filter

Orphan designation – intended use

Decision date

From:

To:

Orphan decision number

Orphan designation status

Positive (123) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Procedure number

Medicine type

Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter Accelerated assessment (62) Apply Accelerated assessment filter Biosimilar (93) Apply Biosimilar filter Conditional approval (79) Apply Conditional approval filter Generic (293) Apply Generic filter Orphan medicine (426) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

541 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Shortages Remove Shortages filter Periodic safety update report single assessments Remove Periodic safety update report single assessments filter Summaries of opinion Remove Summaries of opinion filter Orphan designations Remove Orphan designations filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter Additional monitoring Remove Additional monitoring filter

Sort by

List item

Human medicine European public assessment report (EPAR): Bavencio

avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017, , Revision: 14, Authorised, Last updated: 19/10/2022
List item

Human medicine European public assessment report (EPAR): Benlysta (updated)

belimumab, Lupus Erythematosus, Systemic
Date of authorisation: 13/07/2011, , Revision: 29, Authorised, Last updated: 18/01/2023
List item

Human medicine European public assessment report (EPAR): Beovu (updated)

brolucizumab, Wet Macular Degeneration
Date of authorisation: 13/02/2020, , Revision: 6, Authorised, Last updated: 25/01/2023
List item

Human medicine European public assessment report (EPAR): Besremi (updated)

ropeginterferon alfa-2b, Polycythemia Vera
Date of authorisation: 15/02/2019, , Revision: 4, Authorised, Last updated: 25/01/2023
List item

Human medicine European public assessment report (EPAR): Beyfortus (updated)

nirsevimab,
Date of authorisation: 31/10/2022, , Authorised, Last updated: 30/01/2023
List item

Human medicine European public assessment report (EPAR): Bimzelx

bimekizumab, Psoriasis
Date of authorisation: 20/08/2021, , Revision: 2, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): BindRen

colestilan, Hyperphosphatemia
Date of authorisation: 21/01/2013, , Revision: 2, Withdrawn, Last updated: 01/04/2015
List item

Human medicine European public assessment report (EPAR): Blenrep

belantamab mafodotin, Multiple Myeloma
Date of authorisation: 25/08/2020, , , , Revision: 4, Authorised, Last updated: 12/10/2022
List item

Human medicine European public assessment report (EPAR): Blincyto

blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015, , , Revision: 15, Authorised, Last updated: 22/09/2022
List item

Human medicine European public assessment report (EPAR): Braftovi

Encorafenib, Melanoma; Colorectal Neoplasms
Date of authorisation: 19/09/2018, , Revision: 10, Authorised, Last updated: 05/08/2022
List item

Human medicine European public assessment report (EPAR): Bretaris Genuair (updated)

aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012, , Revision: 18, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Breyanzi

CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ T-cells (CD8+ cells), CD19-directed genetically modified autologous cell-based product consisting of purified CD4+ T cells (CD4+ cells), Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Mediastinal Neoplasms
Date of authorisation: 04/04/2022, , Authorised, Last updated: 20/05/2022
List item

Human medicine European public assessment report (EPAR): Brimica Genuair (updated)

formoterol fumarate dihydrate, aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014, , Revision: 13, Authorised, Last updated: 04/01/2023
List item

Human medicine European public assessment report (EPAR): Brineura

cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017, , , , , Revision: 6, Authorised, Last updated: 16/08/2022
List item

Human medicine European public assessment report (EPAR): Brukinsa

zanubrutinib, Waldenstrom Macroglobulinemia
Date of authorisation: 22/11/2021, , Revision: 4, Authorised, Last updated: 16/12/2022
List item

Human medicine European public assessment report (EPAR): Byfavo (updated)

remimazolam, Conscious Sedation
Date of authorisation: 26/03/2021, , Revision: 3, Authorised, Last updated: 06/01/2023
List item

Human medicine European public assessment report (EPAR): Bylvay

Odevixibat, Cholestasis, Intrahepatic
Date of authorisation: 16/07/2021, , , , Revision: 2, Authorised, Last updated: 05/10/2022
List item

Human medicine European public assessment report (EPAR): Byooviz (updated)

ranibizumab, Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Myopia, Degenerative
Date of authorisation: 18/08/2021, , , Revision: 5, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Cablivi

Caplacizumab, Purpura, Thrombotic Thrombocytopenic
Date of authorisation: 30/08/2018, , , Revision: 6, Authorised, Last updated: 26/07/2022
List item

Human medicine European public assessment report (EPAR): Calquence

Acalabrutinib, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 05/11/2020, , Revision: 3, Authorised, Last updated: 08/12/2021
List item

Human medicine European public assessment report (EPAR): Carvykti (updated)

ciltacabtagene autoleucel, Multiple Myeloma
Date of authorisation: 25/05/2022, , , , Revision: 1, Authorised, Last updated: 17/01/2023
List item

Human medicine European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma)

pegfilgrastim, Neutropenia
Date of authorisation: 19/12/2019, , , Revision: 6, Authorised, Last updated: 05/11/2021
List item

Human medicine European public assessment report (EPAR): Ceplene (updated)

Histamine dihydrochloride, Leukemia, Myeloid, Acute
Date of authorisation: 07/10/2008, , , Revision: 12, Authorised, Last updated: 30/01/2023
List item

Human medicine European public assessment report (EPAR): Cerdelga

eliglustat, Gaucher Disease
Date of authorisation: 19/01/2015, , , Revision: 13, Authorised, Last updated: 11/01/2022
List item

Human medicine European public assessment report (EPAR): Cevenfacta

Eptacog beta (activated), Hemophilia A; Hemophilia B
Date of authorisation: 15/07/2022, , Authorised, Last updated: 29/11/2022